Controversy continues regarding the optimal composition of glucose electrolyte oral rehydration solutions for the treatment of acute diarrhoea. Four perfusion models (normal human jejunum, normal rat small intestine, cholera toxin treated secreting rat small intestine and rotavirus infected rat small intestine) have been developed and used to compare the efficacy of a hypotonic oral rehydration solution with standard United Kingdom British National formulary and developing world oral rehydration solutions (WHO). Despite obvious physiological and pathophysiological differences between these models there was general congruence in the water and solute absorption profiles of the different oral rehydration solutions. Hypotonic oral rehydration solution promoted significantly greater water absorption than other oral rehydration solutions in all rat models (p<O.OOl) but apparently increased water absorption failed to achieve significance in human jejunum. British National Formularyoral rehydration solution was unable to reverse net water secretion in both rotavirus and cholera toxin models. Net sodium absorption from hypotonic and WHO-oral rehydration solutions was signficantly greater than from the low sodium British National Formulary-oral rehydration solutions (p<O.OOl) except in the rotavirus model when absorption was similar to hypotonic-oral rehydration solutions. These findings show that there is agreement in the apparent efficacy of oral rehydration solutions in these animal and human perfusion models, and that improved water absorption with adequate sodium absorption may be achieved by reducing oral rehydration solution osmolality. (Gut 1992; 33: 1652- The ideal method for assessing new oral rehydration solutions is by clinical trial."'"" Such studies are highly demanding and thus the number of solutions which can be tested is limited. Several authors have used animal perfusion models of either healthy" or 'diseased' intestines to assess the ability of oral rehydration solutions to promote water and sodium absorption, while others have evaluated oral rehydration solutions by human jejunal perfusion."'" The comparability between these different model perfusion systems is unknown as is their relevance to the behaviour of oral rehydration solutions in acute diarrhoea. Despite their inherent limitations such studies are the only intermediate form of assessment of oral rehydration solutions that is available.
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The ideal method for assessing new oral rehydration solutions is by clinical trial."'"" Such studies are highly demanding and thus the number of solutions which can be tested is limited. Several authors have used animal perfusion models of either healthy" or 'diseased' intestines to assess the ability of oral rehydration solutions to promote water and sodium absorption, while others have evaluated oral rehydration solutions by human jejunal perfusion."'" The comparability between these different model perfusion systems is unknown as is their relevance to the behaviour of oral rehydration solutions in acute diarrhoea. Despite their inherent limitations such studies are the only intermediate form of assessment of oral rehydration solutions that is available.
We have, therefore, compared net water and solute absorption from three oral rehydration solutions in four perfusion systems: (i) adult rat entire small intestine, (ii) cholera toxin treated adult rat entire small intestine, (iii) rotavirus infected neonatal rat small intestine and (iv) human triple lumen jejunal perfusion. The oral rehydration solutions tested were WHO oral rehydration solutions, the oral rehydration solutions recommended by the British National Formulary, British National Formulary-oral rehydration solution, which is the most widely used in the United Kingdom and a new, experimental hypotonic oral rehydration solution.
Methods

SOLUTION DESIGN
The composition of the oral rehydration solutions is shown in Table I We have examined net water and electrolyte absorption from this candidate solution and compared it with that seen with British National Formulary-oral rehydration solution and the WHO oral rehydration solution in four in vivo perfusion models. We also perfused a glucose free isotonic sodium chloride solution or a plasma electrolyte solution to establish basal transport of water and electrolytes in each model.
INTESTINAL PERFUSION
(i) Perfusion ofadult rat entire small intestine As previously described" male adult Wistar rats (weight 200-220 g) were subjected to laparotomy under pentobartibone anaesthesia. Both the duodenum and distal ileum were cannulated and the entire small intestine perfused at 30 ml/ h. After a 60 minute equilibration period, three 10 minute collections were made. At the end of the experiment the animals were killed by intracardiac injection ofpentobartitone. The perfused segment of intestine was then removed, rinsed and dried in an oven at 90°C for 18 hours. polyethylene glycol recovery in these experiments was 100.3 (3)%. (ii) Cholera toxin treated adult rat entire small intestine An identical operative procedure was used to that outlined in (i). As described previously 75 j,g cholera toxin (Sigma Chemical Company Ltd, Poole, Dorset) was used to induce a secretory state. '5 After two hours, the bowel was cleansed In keeping with other workers`an arbitrary limit of >70% of expected recovery from the proximal port and >30% of remaining marker recovery from the distal port was set for the human triple lumen perfusions.
The composition of all oral rehydration solutions changed with transit through the mixing segment of human jejunum (Table Ila) In all model systems water absorption was greatest from hypotonic-oral rehydration solution. This effect was significant in all animal systems (p<0001) (Fig 1) . In both the secreting models (rat cholera toxin and rat rotavirus) perfusion of British National Formulary oral rehydration solution was associated with net secretion of water. Only in the rat rotavirus model did WHO oral rehydration solution promote greater water absorption (5.8 dul/g/min) than British National Formulary-oral rehydration solution (-37-1 ul/g/min; p<0Q001).
Net sodium absorption (Fig 2) was greater from hypotonic oral rehydration solution and WHO oral rehydration solution than from British National Formulary-oral rehydration solution in rat and human normal intestine (p<0-001). The effect of the high sodium content of WHO oral rehydration solution became apparent in the secretory models where it either promoted absorption (rat rotavirus) or minimal secretion (rat cholera toxin). In the rat rotavirus model hypotonic-oral rehydration solution produced similar net sodium secretion as British National Formulary-oral rehydration solutions. In the rat cholera toxin model, perfusion of all oral rehydration solutions resulted in net sodium secretion but the effect was less marked with WHO oral rehydration solutions (-3.2 gmol/ g/min) and hypotonic-oral rehydration solutions (-4.1 umol/g/min) than British National Formulary-oral rehydration solution (- 9 9 ,umol/g/min; p<0 05).
Differences in net potassium absorption were found only in the normal rat and rat rotavirus models, when British National Formulary-oral rehydration solution promoted greater net potassium absorption (p<0001) than either of the other two oral rehydration solutions (Tables  III and V) .
Only in normal human intestine was chloride absorption seen with British National Formularyoral rehydration solution. All other models showed net chloride secretion (Tables III-VI) . WHO oral rehydration solution and hypotonicoral rehydration solutions promoted equivalent chloride movement in all models except rat rotavirus where chloride absorption was greater from WHO-oral rehydration solution (p<0-01). The bicarbonate containing solutions (British National Formulary-oral rehydration solutions and WHO oral rehydration solutions promoted similar bicarbonate absorption in human and rat intestine (Tables III-VI) .
Glucose absorption was greater from British National Formulary-oral rehydration solution than either of the other solutions in both models of normal intestine and greater from WHO-oral rehydration solution in the rat rotavirus model (Fig III) .
Discussion
Our findings in all model systems suggest that the use ofhypotonic solutions may increase net water absorption above that seen with currently available oral rehydration solutions. This is concordant with the results of other workers in animal perfusion systems and our own in human jejunum. 416 While net sodium absorption was not different when WHO oral rehydration solution and British National Formulary-oral rehydration solution were perfused in the two non-secreting systems, a difference was apparent in the secreting systems. WHO oral rehydration solution promoted net sodium absorption in the rat rotavirus model but did not reverse net secretion in the rat cholera model. Hypotonicoral rehydration solution induced net water absorption in both secreting models but did not promote net sodium absorption in either. The separation of positive water balance and negative sodium balances in animal perfusion studies have been reported previously. 4 The ability of hypotonic-oral rehydration solution to stimulate net water absorption without net sodium absorption in the different models is probably the result of passive water absorption, induced by the osmotic gradient produced with this solution. In normal small intestine the reflection coefficient for sodium chloride is between 0-4-0.9.2°If the value is similar in secreting intestine a solution approximating to half normal saline would be absorbed passively, without any contribution from glucose stimulated active transport and thus 'free' water absorption would occur.
The mechanisms by which secretion occurs in the cholera toxin and rotavirus models are different which explains at least in part the differences in absorption seen with WHO-oral rehydration solution in the two models. Cholera toxin inhibits sodium/hydrogen exchange34 and stimulates active chloride secretion35 which in turn causes passive sodium secretion. In rotavirus infection there is villus shortening and consequent loss of absorptive area but no direct alteration in transport processes. 3' 6 In totavirus infection the villus changes are focal, migrating distally during infection.36 Consequently there are areas of intact small intestine in which absorption is able to occur normally. In V cholerae infection the major transport effects are seen in the proximal jejunum.37 In our model, however, the whole of the small intestine was exposed to cholera toxin and consequently there was probably extensive inhibition of sodium/ hydrogen counter transport, the major factor in sodium absorption in the fasted state.38 Thus, there is greater disruption of the normal active transport system in the cholera toxin model than the rotavirus model. In the former, active sodium absorption from the oral rehydration solutions is solely dependent upon glucose/sodium cotransport, whereas in the rotavirus model both sodium/hydrogen exchange and sodium/glucose cotransport still operate even in shortened villi. The saline perfusion studies showed greater net water and sodium secretion rates in the cholera toxin compared with the rotavirus model which is analogous to the human disease states. In man, cholera results in a stool sodium concentration of 88-140 mmol/l, whereas in rotavirus infection the stool sodium is usually 35 mmol/l.39 Thus, there is both greater sodium secretion and less active sodium absorption in the cholera toxin model than the rotavirus model. These factors combined account for the net negative sodium balance in the former and positive sodium balance in the latter. been used widely and a decrease in childhood mortality from acute diarrhoea occurred in England and Wales at a time when its use increased.' The corollary of this is that net positive sodium balance in small intestinal perfusion studies is not necessary for the efficacy of an oral rehydration solution. Indeed a marked positive balance in these models may be hazardous when the solution is used in clinical practice, as such solutions may promote hypernatraemia as occasionally occurs with WHO-oral rehydration solution.' The ability of even low sodium oral rehydration solutions to repair sodium deficits in acute diarrhoea probably results from effective sodium salvage by the terminal ileum and colon. 38 The contribution of the colon was not studied in any of our models and the ileum was not studied in the human model. Oral rehydration solutions containing 60 mmol/l sodium, like hypotonic-oral rehydration solution have, however, been shown to be as effective clinically as higher sodium oral rehydration solutions and are rarely associated with disturbances of plasma sodium concentration. 28 The goal for the development of future oral rehydration solutions is to produce solutions which are as effective or more so than the existing formulations for correcting dehydration, and which at the same time decrease stool volume and thus water loss. This may be possible, by taking advantage of the high permeability of the proximal jejunum and by using solutions of low osmolality, to maximise passive water absorption. At the same time it is necessary to ensure the delivery of adequate quantities of solute to distal small bowel. While in health glucose does not stimulate a net increase in sodium absorption in the ileum,4' the presence of both electrogenic sodium and water absorption has been demonstrated in vitro in human ileum after exposure to cholera toxin42 and the same positive effects on sodium balance has been shown with the perfusion ofglucose-saline solutions in secreting dog ileum in vivo." A preliminary clinical study with hypotonic-oral rehydration solution indicates that it is effective for rehydration and reduces stool volumes compared with an established slightly hypertonic oral rehydration solution." This observation supports the view that improved efficacy can be achieved by reducing osmolality of standard glucose electrolyte oral rehydration solutions and gives further credence to the value of animal models for screening new oral rehydration solution formulations. 
